A new severe congenital neutropenia syndrome associated with autosomal recessive COPZ1 mutations.
Borbaran Bravo N +28 more
europepmc +1 more source
Absence of Neutropenia in Patients With Early Exon Nonsense Mutations in ELANE : Clinical Evidence to Support Gene Therapy Approaches for Severe Congenital Neutropenia. [PDF]
Joos M +3 more
europepmc +1 more source
CRISPR-Cas9n-mediated ELANE promoter editing for gene therapy of severe congenital neutropenia. [PDF]
Nasri M +13 more
europepmc +1 more source
Reduced toxicity matched sibling bone marrow transplant results in excellent outcomes for severe congenital neutropenia. [PDF]
Oved JH +6 more
europepmc +1 more source
Case report: Granulocyte-macrophage colony-stimulating factor sargramostim did not rescue the neutrophil phenotype in two patients with JAGN1-mutant severe congenital neutropenia. [PDF]
Farmand S +8 more
europepmc +1 more source
Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia. [PDF]
Matsumura R +8 more
europepmc +1 more source
Related searches:
Congenital neutropenia is strictly defined as neutropenia present at birth. However, it is more generally used to describe neutropenia secondary to inherited genetic mutations. This review will discuss the presentation of such children and the various causes of congenital neutropenia.
exaly +3 more sources
Defective Myelopoiesis in Congenital Neutropenia
New England Journal of Medicine, 1970Abstract Two patients with congenital neutropenia were found to have abnormalities of the immature myeloid cells. These cells were incapable of complete differentiation to a mature stage and also had a substantial reduction in their capacity for cell proliferation.
Alvin M Mauer, E Kauder, A M Mauer
exaly +3 more sources
Pegfilgrastim in children with severe congenital neutropenia
AbstractTwo pediatric patients affected by severe congenital neutropenia (SCN) were treated with 100 mcg/L/dose every 9–12 days within a pilot study (Observatory of the Italian Ministry of Health, Eudract Code 2005‐003096‐20) on the use of pegfilgrastim in patients with chronic neutropenia.
F. Fioredda +9 more
openaire +4 more sources

